Cencora, Inc. - Common Stock (COR)

Historical Holders from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
COR on NYSE
Shares outstanding
193,951,519
Price per share
$337.75
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
178,034,635
Total reported value
$55,589,536,851
% of total 13F portfolios
0.03%
Share change
+1,303,739
Value change
+$449,826,082
Number of holders
1,334
Price from insider filings
$337.75
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cencora, Inc. - Common Stock (COR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 12% $6,740,322,453 22,478,981 The Vanguard Group 30 Jun 2025
BlackRock, Inc. 8.5% $4,760,462,571 16,405,771 BlackRock, Inc. 31 Dec 2024
Walgreens Boots Alliance, Inc. 5% -8.8% $2,682,585,000 -$213,435,000 9,615,000 -7.4% Walgreens Boots Alliance, Inc. 09 Jun 2025
As of 30 Sep 2025, Cencora, Inc. - Common Stock (COR) has 1,334 institutional shareholders filing 13F forms. They hold 178,034,635 shares. of 193,951,519 outstanding shares (92%) .

Top 25 institutional shareholders own 60% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 12% 23,395,547 +4.1% 0.11% $7,311,810,304
BlackRock, Inc. 10% 19,777,491 +5.7% 0.11% $6,181,058,977
STATE STREET CORP 4.7% 9,190,316 +9.3% 0.1% $2,872,249,459
PRICE T ROWE ASSOCIATES INC /MD/ 4% 7,723,900 -0.91% 0.26% $2,413,951,000
GEODE CAPITAL MANAGEMENT, LLC 2.7% 5,290,421 +11% 0.11% $1,647,144,755
JPMORGAN CHASE & CO 2.4% 4,677,797 +20% 0.09% $1,461,965,221
Boston Partners 2.3% 4,509,165 +2% 1.4% $1,409,152,029
Invesco Ltd. 2.1% 4,006,113 -0.79% 0.2% $1,252,030,402
WELLINGTON MANAGEMENT GROUP LLP 2% 3,971,121 +3% 0.22% $1,241,094,446
BANK OF AMERICA CORP /DE/ 2% 3,964,473 -16% 0.09% $1,239,016,626
MORGAN STANLEY 1.7% 3,340,707 +8.2% 0.06% $1,044,071,948
FMR LLC 1.7% 3,311,410 +5.7% 0.05% $1,034,914,731
Capital Research Global Investors 1.4% 2,661,033 +0.59% 0.16% $831,652,643
T. Rowe Price Investment Management, Inc. 1.3% 2,576,296 +327% 0.49% $805,170,000
NORTHERN TRUST CORP 1.2% 2,272,464 +5.9% 0.09% $710,213,174
MARSHALL WACE, LLP 1% 1,995,118 +519% 0.68% $623,534,230
BESSEMER GROUP INC 0.97% 1,888,722 -8.7% 0.9% $590,281,000
VIKING GLOBAL INVESTORS LP 0.92% 1,778,135 -15% 1.4% $555,720,532
Amundi 0.86% 1,658,589 -3.6% 0.16% $506,367,224
GOLDMAN SACHS GROUP INC 0.83% 1,602,889 +8.7% 0.07% $500,950,944
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.76% 1,475,859 +529% 0.1% $461,250,214
DIMENSIONAL FUND ADVISORS LP 0.76% 1,475,170 -0.46% 0.1% $460,997,016
Legal & General Group Plc 0.74% 1,441,755 +6.3% 0.1% $450,591,687
Swedbank AB 0.72% 1,399,123 -0.06% 0.44% $437,267,911
WELLS FARGO & COMPANY/MN 0.71% 1,377,238 -16% 0.09% $430,428,349

Institutional Holders of Cencora, Inc. - Common Stock (COR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 2,461,486 $836,127,647 +$73,924,069 $337.75 78
2025 Q3 178,034,635 $55,589,536,851 +$449,826,082 $312.53 1,334
2025 Q2 184,305,787 $55,237,306,581 -$156,557,329 $299.85 1,332
2025 Q1 185,432,450 $51,572,943,235 -$2,176,096,083 $278.09 1,276
2024 Q4 193,624,028 $43,527,319,060 +$126,454,776 $224.68 1,216
2024 Q3 192,645,051 $43,376,425,534 -$1,022,988,419 $225.08 1,151
2024 Q2 196,987,201 $44,374,547,085 +$291,041,912 $225.30 1,128
2024 Q1 196,055,023 $47,610,586,760 +$36,365,827 $242.99 1,143
2023 Q4 169,402,915 $34,792,116,066 +$1,057,193,028 $205.38 1,073
2023 Q3 163,800,445 $29,500,837,104 +$846,056,057 $179.97 966
2023 Q2 159,099,312 $30,563,299,168 +$609,358,311 $192.43 997
2023 Q1 155,361,895 $24,878,992,155 +$535,210,813 $160.11 930
2022 Q4 153,609,147 $25,442,770,889 +$1,881,740,243 $165.71 969
2022 Q3 142,929,960 $19,380,264,681 -$40,535,017 $135.33 877
2022 Q2 142,616,744 $20,179,412,085 +$881,286,466 $141.48 882
2022 Q1 137,481,836 $21,266,943,430 +$446,997,474 $154.71 880
2021 Q4 134,863,306 $17,918,255,871 +$255,937,284 $132.89 849
2021 Q3 132,988,894 $15,886,064,854 -$64,811,380 $119.45 780
2021 Q2 133,529,140 $15,284,840,931 +$50,454,645 $114.49 781
2021 Q1 132,954,733 $15,692,224,672 +$244,238,636 $118.07 759
2020 Q4 131,476,972 $12,852,756,480 -$56,077,415 $97.76 763
2020 Q3 132,644,887 $12,844,894,440 -$105,591,704 $96.92 734
2020 Q2 132,899,146 $13,381,711,136 +$250,296,081 $100.77 726
2020 Q1 130,544,818 $11,547,042,489 -$443,110,986 $88.50 683
2019 Q4 135,999,026 $11,557,673,304 -$200,865,947 $85.02 705
2019 Q3 136,378,704 $11,224,934,497 -$130,898,983 $82.33 690
2019 Q2 137,744,844 $11,745,991,487 +$19,054,506 $85.26 688
2019 Q1 138,809,250 $11,039,024,457 +$87,504,022 $79.52 690
2018 Q4 138,165,884 $10,279,839,346 -$90,151,941 $74.40 697
2018 Q3 138,938,688 $12,810,309,890 -$366,283,937 $92.22 690
2018 Q2 142,793,616 $12,175,638,495 -$185,547,335 $85.27 716
2018 Q1 146,411,464 $12,600,038,248 -$117,693,651 $86.21 723
2017 Q4 145,712,520 $13,375,638,004 -$104,305,347 $91.82 723
2017 Q3 147,551,501 $12,198,514,057 -$132,336,414 $82.75 688
2017 Q2 148,611,272 $14,047,490,317 -$24,126,787 $94.53 706
2017 Q1 151,306,856 $13,385,994,977 +$1,627,943,237 $88.50 713
2016 Q4 145,638,620 $11,384,254,719 -$698,146,042 $78.19 688
2016 Q3 153,860,001 $12,417,178,526 -$381,169,792 $80.78 673
2016 Q2 159,293,689 $12,631,976,941 -$1,133,891,112 $79.32 677
2016 Q1 173,711,156 $15,026,637,338 -$239,375,754 $86.55 678
2015 Q4 176,281,194 $18,266,785,774 +$733,998,648 $103.71 706
2015 Q3 168,812,466 $16,026,973,253 -$73,739,088 $94.99 688
2015 Q2 169,527,201 $18,020,536,566 -$2,202,637,715 $106.34 705
2015 Q1 189,561,327 $21,531,287,892 +$286,427,131 $113.67 669
2014 Q4 188,369,166 $16,991,181,772 -$146,030,915 $90.16 648
2014 Q3 188,282,063 $14,555,324,113 -$222,208,459 $77.30 590
2014 Q2 190,780,536 $13,862,727,379 +$175,284,663 $72.66 581
2014 Q1 189,712,305 $12,441,406,565 -$396,165,732 $65.59 572